Pharmaceutical Industry | Business Ethics

Decisions in recent legal cases are fueling debate about whether the First Amendment’s protection of commercial speech could undermine the FDA’s ability to prevent drug marketing abuses.

Business Ethics, Corporate Social Responsibility

Drug Industry Lobbyists and Campaign Cash Stymie Bid to Restrain Medicare Prescription Costs

Business Ethics, Regulation & Legislation

Vying for Market Share, Companies Heavily Promote ‘Me Too’ Drugs

Business Ethics, Corporate Social Responsibility, Governance & Compliance

The Magazine of Corporate Responsibility

Tag: Pharmaceutical Industry

Direct-to-consumer drug advertising spikes demand

First Amendment Claims Seen as Rx for Drug Makers, Headache for Consumers

Vying for Market Share, Companies Heavily Promote ‘Me Too’ Drugs

Tag: Pharmaceutical Industry

Direct-to-consumer drug advertising spikes demand

First Amendment Claims Seen as Rx for Drug Makers, Headache for Consumers

Drug Industry Lobbyists and Campaign Cash Stymie Bid to Restrain Medicare Prescription Costs

Vying for Market Share, Companies Heavily Promote ‘Me Too’ Drugs

The Corporate Capture of the United States